Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection [Phase 2]
Phase 2 trial evaluating Expanded Activated Lymphocytes as adjuvant therapy to reduce recurrence in hepatocellular carcinoma after surgical …
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy [Phase 2]
Phase 2 study of TAC-101 as second-line treatment in advanced hepatocellular carcinoma after sorafenib was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment [Phase 4]
Phase 4 clinical trial evaluating recombinant human adenovirus type 5 in advanced hepatocellular carcinoma patients with stable disease afte…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma [Phase 1, Phase 2]
A clinical trial update for P1101 and Anti-PD1 in patients after curative surgery for hepatitis B-related hepatocellular carcinoma, spanning…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial [Phase 2]
Phase II trial evaluating RFA or surgical resection combined with Neo-MASCT for primary hepatocellular carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma [Phase 3]
Phase 3 trial investigating radiofrequency ablation plus radiotherapy for small hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: HR Versus RFA for HCC in Patients With PHT [Phase 3]
Phase 3 trial comparing HR versus RFA for hepatocellular carcinoma in patients with portal hypertension; status unknown.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients [Phase 2]
Phase 2 clinical trial update evaluating HLX10 in combination with HLX04 for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE [NA]
Clinical trial evaluating a bridge-to-transplant approach for hepatocellular carcinoma patients awaiting liver transplantation; study termin…
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection [Phase 2]
Phase 2 study evaluating TACE sequential tislelizumab as adjuvant therapy for hepatocellular carcinoma at high risk of recurrence after cura…
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in combination with Yttrium-90 glass microspheres for unresectable liver cancer (hepatocellular …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 randomized, double-blind trial of CF102 in hepatocellular carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC [Phase 2]
A Phase 2 trial evaluating camrelizumab in combination with apatinib and NK cells for advanced hepatocellular carcinoma is ongoing, with sta…
-
CLINICAL_TRIALS trial_result · 2021-12-27Clinical Trial Update: Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update evaluating high-dose conformational radiotherapy and hyperselective transarterial chemoembolization for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating donafenib combined with sintilimab and hepatic artery infusion chemotherapy as first-line treatment for un…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating donafenib combined with TACE as adjuvant therapy for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update assessing durvalumab and tremelimumab as monotherapy or in combination (durvalumab plus tremelimumab) or with bevacizum…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Trial Comparing PLA to HIGRT (PROVE-HCC) [NA]
A terminated clinical trial (PROVE-HCC) comparing PLA to HIGRT in hepatocellular carcinoma with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: SBRT or TACE for Advanced HCC [Phase 3]
Phase 3 trial update comparing SBRT versus TACE for advanced hepatocellular carcinoma is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer [Phase 3]
A Phase 3 trial evaluating HepaSphere/Quadrasphere microspheres delivering doxorubicin for hepatocellular carcinoma was terminated with resu…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure [Phase 2]
Phase 2 trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with camrelizumab and tyrosine kinase inhibitor (TKI) for un…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase II single-arm study evaluating toripalimab with bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
Clinical trial evaluating the safety and efficacy of combining Pexa-Vec with nivolumab in first-line advanced hepatocellular carcinoma; the …
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [Phase 3]
Phase 3 trial comparing atezolizumab with bevacizumab versus sorafenib in untreated locally advanced or metastatic hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation [Phase 3]
Phase 3 clinical trial evaluating neo-adjuvant transarterial chemoinfusion for hepatocellular carcinoma patients beyond Milan/UCSF criteria …